<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<title>S4043</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Albertus Extra Bold";
	panose-1:2 14 8 2 4 3 4 2 2 4;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-link:"Comment Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	background:navy;
	font-size:12.0pt;
	font-family:"Tahoma",sans-serif;}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{mso-style-link:"Comment Subject Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;
	font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:9.0pt;
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.11ptChar
	{mso-style-name:11ptChar;
	font-family:"Times New Roman",serif;}
span.BillHead
	{mso-style-name:BillHead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeading2
	{mso-style-name:BillHeading2;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeadUnBold
	{mso-style-name:BillHeadUnBold;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
span.BillLanguage
	{mso-style-name:BillLanguage;
	font-family:"Times New Roman",serif;
	font-style:italic;}
p.bpuBill, li.bpuBill, div.bpuBill
	{mso-style-name:bpuBill;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:26.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuHeadSpon, li.bpuHeadSpon, div.bpuHeadSpon
	{mso-style-name:bpuHeadSpon;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.bpuHeadSponChar
	{mso-style-name:bpuHeadSponChar;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuIntro, li.bpuIntro, div.bpuIntro
	{mso-style-name:bpuIntro;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.bpuLegislature, li.bpuLegislature, div.bpuLegislature
	{mso-style-name:bpuLegislature;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:24.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuNormText, li.bpuNormText, div.bpuNormText
	{mso-style-name:bpuNormText;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuReprint, li.bpuReprint, div.bpuReprint
	{mso-style-name:bpuReprint;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:22.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.bpuSponsor, li.bpuSponsor, div.bpuSponsor
	{mso-style-name:bpuSponsor;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuState, li.bpuState, div.bpuState
	{mso-style-name:bpuState;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:32.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
span.charMarlett
	{mso-style-name:charMarlett;
	font-family:Marlett;}
p.ElevenPt, li.ElevenPt, div.ElevenPt
	{mso-style-name:ElevenPt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage, li.FronterPage, div.FronterPage
	{mso-style-name:FronterPage;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage12pt, li.FronterPage12pt, div.FronterPage12pt
	{mso-style-name:FronterPage12pt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageBillHeading, li.FronterPageBillHeading, div.FronterPageBillHeading
	{mso-style-name:FronterPageBillHeading;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FronterPageTBox2, li.FronterPageTBox2, div.FronterPageTBox2
	{mso-style-name:FronterPageTBox2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageTextBox, li.FronterPageTextBox, div.FronterPageTextBox
	{mso-style-name:FronterPageTextBox;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.FronterSameAs, li.FronterSameAs, div.FronterSameAs
	{mso-style-name:FronterSameAs;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.HangingAnAct, li.HangingAnAct, div.HangingAnAct
	{mso-style-name:HangingAnAct;
	mso-style-link:"HangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.HangingAnActChar
	{mso-style-name:"HangingAnAct Char";
	mso-style-link:HangingAnAct;
	letter-spacing:.2pt;}
span.Para10pt
	{mso-style-name:Para10pt;
	font-family:"Times New Roman",serif;}
p.Pg2Footer, li.Pg2Footer, div.Pg2Footer
	{mso-style-name:Pg2Footer;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.StyleFronterPage11pt, li.StyleFronterPage11pt, div.StyleFronterPage11pt
	{mso-style-name:"Style FronterPage + 11 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.StyleFronterPageLoweredby3pt, li.StyleFronterPageLoweredby3pt, div.StyleFronterPageLoweredby3pt
	{mso-style-name:"Style FronterPage + Lowered by  3 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	position:relative;
	top:3.0pt;}
p.StyleFronterSameAsPatternSolid100White, li.StyleFronterSameAsPatternSolid100White, div.StyleFronterSameAsPatternSolid100White
	{mso-style-name:"Style FronterSameAs + Pattern\: Solid \(100%\) \(White\)";
	margin:0in;
	margin-bottom:.0001pt;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Whereas
	{mso-style-name:Whereas;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.Style10pt
	{mso-style-name:"Style 10 pt";
	font-family:"Times New Roman",serif;}
p.FronterPageNOCAPS, li.FronterPageNOCAPS, div.FronterPageNOCAPS
	{mso-style-name:FronterPageNOCAPS;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuWpGraphic, li.bpuWpGraphic, div.bpuWpGraphic
	{mso-style-name:bpuWpGraphic;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.sponUdate, li.sponUdate, div.sponUdate
	{mso-style-name:sponUdate;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.fronterpagebillhead
	{mso-style-name:fronterpagebillhead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FPHangingAnAct, li.FPHangingAnAct, div.FPHangingAnAct
	{mso-style-name:FPHangingAnAct;
	mso-style-link:"FPHangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.4in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.FPHangingAnActChar
	{mso-style-name:"FPHangingAnAct Char";
	mso-style-link:FPHangingAnAct;
	letter-spacing:.2pt;}
span.LeftBrackt
	{mso-style-name:LeftBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.RightBrackt
	{mso-style-name:RightBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.BoldItal
	{mso-style-name:BoldItal;
	font-weight:bold;
	font-style:italic;}
p.HangingSup, li.HangingSup, div.HangingSup
	{mso-style-name:HangingSup;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableBottom, li.HangingTableBottom, div.HangingTableBottom
	{mso-style-name:HangingTableBottom;
	margin-top:0in;
	margin-right:1.0in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableTop, li.HangingTableTop, div.HangingTableTop
	{mso-style-name:HangingTableTop;
	margin-top:0in;
	margin-right:.5in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
span.CommentTextChar
	{mso-style-name:"Comment Text Char";
	mso-style-link:"Comment Text";
	letter-spacing:.2pt;}
span.CommentSubjectChar
	{mso-style-name:"Comment Subject Char";
	mso-style-link:"Comment Subject";
	letter-spacing:.2pt;
	font-weight:bold;}
.MsoChpDefault
	{font-size:10.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 14.0in;
	margin:1.5in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:8.5in 14.0in;
	margin:1.0in 113.75pt 1.0in 113.75pt;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:8.5in 14.0in;
	margin:1.0in 1.75in 1.3in 2.0in;}
div.WordSection3
	{page:WordSection3;}
 /* List Definitions */
 ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>

</head>

<body lang=EN-US>

<div class=WordSection1>

<p class=bpuBill><a name=bpuFrontPg></a>SENATE, No. 4043 </p>

<p class=bpuWpGraphic><b><span style='font-size:32.0pt;line-height:120%;
font-family:"Arial",sans-serif;letter-spacing:0pt'>STATE OF NEW JERSEY</span></b></p>

<p class=bpuLegislature>221st LEGISLATURE</p>

<p class=bpuWpGraphic>  </p>

<p class=bpuIntro>INTRODUCED JANUARY 14, 2025</p>

<p class=bpuIntro>&nbsp;</p>

</div>

<span style='font-size:11.0pt;line-height:120%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:auto'>
</span>

<div class=WordSection2>

<p class=bpuIntro>&nbsp;</p>

<p class=bpuSponsor>Sponsored by:</p>

<p class=bpuSponsor>Senator  NILSA I. CRUZ-PEREZ</p>

<p class=bpuSponsor>District 5 (Camden and Gloucester)</p>

<p class=bpuSponsor>Senator  NICHOLAS P. SCUTARI</p>

<p class=bpuSponsor>District 22 (Somerset and Union)</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>Co-Sponsored by:</p>

<p class=bpuSponsor>Senator Burgess</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>SYNOPSIS</p>

<p class=bpuNormText>     Increases access to substance use disorder treatment;
Requires Medicaid coverage for substance use disorder services provided by
community-based organizations. </p>

<p class=bpuNormText>&nbsp;</p>

<p class=bpuSponsor>CURRENT VERSION OF TEXT </p>

<p class=bpuNormText>     As introduced.</p>

<p class=bpuNormText>   </p>

</div>

<span style='font-size:12.0pt;line-height:120%;font-family:"Times New Roman",serif;
letter-spacing:.2pt'><br clear=all style='page-break-before:always'>
</span>

<div class=WordSection3>

<p class=HangingAnAct style='line-height:150%'><span class=BillHead>An Act</span><span
class=HangingAnActChar> </span>concerning substance use disorder treatment and
supplementing and amending various parts of statutory law.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     <span class=BillHeading2>Be It
Enacted </span><span class=BillLanguage>by the Senate and General Assembly of
the State of New Jersey:</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     1.  (New section)  As used in
P.L.    , c.    (C.        ) (pending before the Legislature as this bill):</p>

<p class=MsoNormal style='line-height:150%'>     Medication for opioid use
disorder means a medication, including an opioid agonist medication, approved
by the federal Food and Drug Administration under section 505 of the federal
Food, Drug, and Cosmetic Act, 21 U.S.C. s.355, for use in the treatment of opioid
use disorders.</p>

<p class=MsoNormal style='line-height:150%'>     Medication unit means an
entity that is established as part of, but geographically separate from, an opioid
treatment program from which appropriately licensed opioid treatment program
practitioners, contractors working on behalf of the opioid treatment program,
or community pharmacists may dispense or administer medication for opioid used
disorder, collect samples for drug testing or analysis, or provide other opioid
treatment program services.  Medication units can be a brick-and-mortar location
or mobile unit.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Multidisciplinary
team&quot; means those persons representing different professions, disciplines,
and service areas, who work together to provide treatment planning and care to
a patient in an opioid treatment program.</p>

<p class=MsoNormal style='line-height:150%'>     Opioid treatment program
means a program certified as an opioid treatment program by the federal
Substance Abuse and Mental Health Services Administration and licensed to
operate as an opioid treatment program in this State by the Department of
Health.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     2. (New section) a.  An opioid
treatment program may voluntarily establish a medication unit with the
appropriate licensure from the Department of Health, the United States Drug
Enforcement Agency, the federal Substance Abuse and Mental Health Services Administration,
and the New Jersey State Board of Pharmacy.  A medication unit shall be
associated with a single primary opioid treatment program that will oversee the
units operations.  All required services that cannot be performed at the
medication unit shall be performed by the primary opioid treatment program.</p>

<p class=MsoNormal style='line-height:150%'>     b.  A medication unit may
provide the following services if the unit provides appropriate privacy and
adequate space:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   intake and initial
psychosocial and appropriate medical assessments with a full physical
examination to be completed or provided within 14 days of admission;</p>

<p class=MsoNormal style='line-height:150%'>     (2)   initiation of medication
assisted-treatment including, but not limited to, methadone, buprenorphine, or
naltrexone after an appropriate medical assessment has been performed, provided
that the initiation of methadone shall be performed by a qualified healthcare
professional and monitored following appropriate medical practices; and</p>

<p class=MsoNormal style='line-height:150%'>     (3)   telecounseling services
provided by appropriately credentialed staff in accordance with all applicable
federal and State regulations.</p>

<p class=MsoNormal style='line-height:150%'>     c.  Notwithstanding the
provisions of any State law, rule, or regulation to the contrary, an opioid
treatment program shall not be required to engage, employ, or contract with a
pharmacist.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     3. (New section)  a.  Each
opioid treatment program shall provide or coordinate harm reduction services
for each patient as appropriate to the patients treatment plan.</p>

<p class=MsoNormal style='line-height:150%'>     b.  Each opioid treatment
program shall establish a counseling schedule for each patient based on an
individualized treatment plan approved and documented by the multidisciplinary
treatment team providing care to the patient, in accordance with applicable federal
and State law and regulation. </p>

<p class=MsoNormal style='line-height:150%'>     c.  Notwithstanding the
provisions of any State law, rule, or regulation to the contrary, a patient
shall not be precluded from receiving treatment or medication for opioid use
disorder from an opioid treatment program solely on the basis of the patients
refusal of counseling.</p>

<p class=MsoNormal style='line-height:150%'>     d.  Notwithstanding the
provisions of any State law, rule, or regulation to the contrary, an opioid
treatment program shall not have a discharge policy that permits the
administrative discharge of a patient due to missed doses, non-participation,
and continued illicit substance use, unless the risk of continued illicit
substance use outweighs the risk of overdose death following termination of
opioid use disorder treatment. </p>

<p class=MsoNormal style='line-height:150%'>     e.  Notwithstanding the
provisions of any State law, rule, or regulation to the contrary, an opioid
treatment program may only require a patient to receive a minimum of eight
random drug screenings per year.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     4. (New section) A patient
shall report to the same opioid treatment program unless prior written approval
is obtained from the program physician allowing the patient to receive
treatment at another opioid treatment program.  If permission is granted, the opioid
treatment programs involved shall meet the following requirements:</p>

<p class=MsoNormal style='line-height:150%'>     a.  the opioid treatment
program referring the patient shall notify and obtain, in writing, permission
from the other opioid treatment program for the patient to attend;</p>

<p class=MsoNormal style='line-height:150%'>     b.  the maximum period of time
that a patient may attend another opioid treatment program shall be 30 days;</p>

<p class=MsoNormal style='line-height:150%'>     c.  during attendance at
another program, the patient may not receive more opioid agonist treatment
medication take-home doses than currently authorized by the patients regular opioid
treatment program; and</p>

<p class=MsoNormal style='line-height:150%'>     d.  the opioid treatment
program making the referral shall provide the patient with positive
identification for presentation to the other opioid treatment program.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     5.  Section 1 of P.L.1982,
c.149 (C.26:2H-11.1) is amended to read as follows:</p>

<p class=MsoNormal style='line-height:150%'>     1.    In the case of an application
for <b><span style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>a
certificate of need or<b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b>
initial licensure<b><span style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>,
as applicable,<b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b>
for a <b><span style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>narcotic
and drug abuse<b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b>
<u>substance use disorder</u> treatment center to be located within 500 feet
from any building in this State used for the instruction of children between
the ages of five and 18 years, the applicant shall notify the governing body of
the municipality within which the applicant proposes to locate the treatment
center of the applicant's intention to apply for <b><span style='font-family:
"Albertus Extra Bold",sans-serif'>[</span></b>the certificate of need or<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> licensure and
the proposed location of the center. Documentation of the notice shall be filed
with the <b><span style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>certificate
of need or<b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b>
license application.  The Commissioner of Health is hereby authorized to adopt
reasonable rules and regulations, in accordance with the provisions of the
&quot;Administrative Procedure Act,&quot; P.L.1968, c.410 (C.52:14B-1 et seq.),
to effectuate the purposes of this act.  For the purposes of this act, the
definition of &quot;<b><span style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>narcotic
and drug abuse<b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b>
<u>substance use disorder</u> treatment center&quot; shall be identical to the
definition in subsection (a) of section 2 of P.L.1970, c.334 (C.26:2G-22). 
This act shall not apply to any <b><span style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>narcotic
and drug abuse<b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b>
<u>substance use disorde</u>r use treatment center for which an application was
filed prior to the effective date of this act.</p>

<p class=MsoNormal style='line-height:150%'>(cf: P.L.2012, c.17, s.177)</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     6.    a.  The Commissioner of
Health, in consultation with the Commissioner of Human Services, shall
establish standards and requirements for the licensure of community-based
organizations to provide substance use disorder services to Medicaid recipients
and for the provision of substance use disorder services by licensed
community-based organizations.</p>

<p class=MsoNormal style='line-height:150%'>     b.  No community-based
organization shall be approved for reimbursement by the Division of Medical
Assistance and Health Services in the Department of Human Services for
substance use disorder services rendered to Medicaid recipients, unless such
community-based organization meets all the standards and requirements issued
pursuant to subsection a. of this section.</p>

<p class=MsoNormal style='line-height:150%'>     c.  The Commissioner of Health
shall establish a program to provide training and technical assistance to help
community-based organizations meet any licensure and provider enrollment
standards established by the commissioner and the Medicaid program.</p>

<p class=MsoNormal style='line-height:150%'>     d.  As used in this section:</p>

<p class=MsoNormal style='line-height:150%'>     Community-based organization
means a community-based organization licensed by the Department of Health to
provide substance use disorder services to Medicaid recipients pursuant to this
section.  A community-based organization may include, but is not limited to,
a harm reduction center.</p>

<p class=MsoNormal style='line-height:150%'>     Medicaid means the Medicaid
program established pursuant to P.L.1968, c.413 (C.30:4D-1 et seq.).</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     7.  Section 6 of P.L.1968,
c.413 (C.30:4D-6) is amended to read as follows:</p>

<p class=MsoNormal style='line-height:150%'>     6.  a.  Subject to the requirements
of Title XIX of the federal Social Security Act, the limitations imposed by
this act and by the rules and regulations promulgated pursuant thereto, the
department shall provide medical assistance to qualified applicants, including
authorized services within each of the following classifications:</p>

<p class=MsoNormal style='line-height:150%'>     (1) Inpatient hospital
services<u>;</u></p>

<p class=MsoNormal style='line-height:150%'>     (2) Outpatient hospital
services;</p>

<p class=MsoNormal style='line-height:150%'>     (3) Other laboratory and X-ray
services;</p>

<p class=MsoNormal style='line-height:150%'>     (4) (a) Skilled nursing or
intermediate care facility services;</p>

<p class=MsoNormal style='line-height:150%'>     (b) Early and periodic screening
and diagnosis of individuals who are eligible under the program and are under
age 21, to ascertain their physical or mental health status and the health
care, treatment, and other measures to correct or ameliorate defects and
chronic conditions discovered thereby, as may be provided in regulation of the
Secretary of the federal Department of Health and Human Services and approved
by the commissioner;<u> and</u></p>

<p class=MsoNormal style='line-height:150%'>     (5) Physician's services
furnished in the office, the patient's home, a hospital, a skilled nursing, or
intermediate care facility or elsewhere.</p>

<p class=MsoNormal style='line-height:150%'>     As used in this subsection,
&quot;laboratory and X-ray services&quot; includes HIV drug resistance testing,
including, but not limited to, genotype assays that have been cleared or
approved by the federal Food and Drug Administration, laboratory developed
genotype assays, phenotype assays, and other assays using phenotype prediction
with genotype comparison, for persons diagnosed with HIV infection or AIDS.</p>

<p class=MsoNormal style='line-height:150%'>     b.    Subject to the
limitations imposed by federal law, by this act, and by the rules and
regulations promulgated pursuant thereto, the medical assistance program may be
expanded to include authorized services within each of the following
classifications:</p>

<p class=MsoNormal style='line-height:150%'>     (1) Medical care not included
in subsection a.(5) above, or any other type of remedial care recognized under
State law, furnished by licensed practitioners within the scope of their
practice, as defined by State law;</p>

<p class=MsoNormal style='line-height:150%'>     (2) Home health care services;</p>

<p class=MsoNormal style='line-height:150%'>     (3) Clinic services;</p>

<p class=MsoNormal style='line-height:150%'>     (4) Dental services;</p>

<p class=MsoNormal style='line-height:150%'>     (5) Physical therapy and
related services;</p>

<p class=MsoNormal style='line-height:150%'>     (6) Prescribed drugs,
dentures, and prosthetic devices; and eyeglasses prescribed by a physician
skilled in diseases of the eye or by an optometrist, whichever the individual
may select;</p>

<p class=MsoNormal style='line-height:150%'>     (7) Optometric services;</p>

<p class=MsoNormal style='line-height:150%'>     (8) Podiatric services;</p>

<p class=MsoNormal style='line-height:150%'>     (9) Chiropractic services;</p>

<p class=MsoNormal style='line-height:150%'>     (10) Psychological services;</p>

<p class=MsoNormal style='line-height:150%'>     (11) Inpatient psychiatric
hospital services for individuals under 21 years of age, or under age 22 if
they are receiving such services immediately before attaining age 21;</p>

<p class=MsoNormal style='line-height:150%'>     (12) Other diagnostic,
screening, preventative, and rehabilitative services, and other remedial care;</p>

<p class=MsoNormal style='line-height:150%'>     (13) Inpatient hospital
services, nursing facility services, and immediate care facility services for
individuals 65 years of age or over in an institution for mental diseases;</p>

<p class=MsoNormal style='line-height:150%'>     (14) Intermediate care
facility services;</p>

<p class=MsoNormal style='line-height:150%'>     (15) Transportation services;</p>

<p class=MsoNormal style='line-height:150%'>     (16) Services in connection
with the inpatient or outpatient treatment or care of substance use disorder,
when the treatment is prescribed by a physician and provided in a licensed
hospital or in a narcotic and substance use disorder treatment center approved
by the Department of Health pursuant to P.L.1970, c.334 (C.26:2G-21 et. seq.)
and whose staff includes a medical director, and limited those services
eligible for federal financial participation under Title XIX of the federal
Social Security Act;</p>

<p class=MsoNormal style='line-height:150%'>     (17) Any other medical care
and any other type of remedial care recognized under State law, specified by
the Secretary of the federal Department of Health and Human Services, and
approved by the commissioner;</p>

<p class=MsoNormal style='line-height:150%'>     (18) Comprehensive maternity
care, which may include: the basic number of prenatal and postpartum visits
recommended by the American College of Obstetrics and Gynecology; additional
prenatal and postpartum visits that are medically necessary; necessary
laboratory, nutritional assessment and counseling, health education, personal
counseling, managed care, outreach, and follow-up services; treatment of
conditions which may complicate pregnancy doula care; and physician or certified
nurse midwife delivery services.  For the purposes of this paragraph,
&quot;doula&quot; means a trained professional who provides continuous
physical, emotional, and informational support to a mother before, during, and
shortly after childbirth, to help her to achieve the healthiest, most
satisfying experience possible;</p>

<p class=MsoNormal style='line-height:150%'>     (19) Comprehensive pediatric
care, which may include: ambulatory, preventive, and primary care health
services.  The preventive services shall include, at a minimum, the basic
number of preventive visits recommended by the American Academy of Pediatrics;</p>

<p class=MsoNormal style='line-height:150%'>     (20) Services provided by a
hospice which is participating in the Medicare program established pursuant to
Title XVIII of the Social Security Act, Pub.L.89-97 (42 U.S.C. s.1395 et
seq.).  Hospice services shall be provided subject to approval of the Secretary
of the federal Department of Health and Human Services for federal
reimbursement;</p>

<p class=MsoNormal style='line-height:150%'>     (21) Mammograms, subject to
approval of the Secretary of the federal Department of Health and Human Services
for federal reimbursement, including one baseline mammogram for women who are
at least 35 but less than 40 years of age; one mammogram examination every two
years or more frequently, if recommended by a physician, for women who are at
least 40 but less than 50 years of age; and one mammogram examination every
year for women age 50 and over;</p>

<p class=MsoNormal style='line-height:150%'>     (22) Upon referral by a
physician, advanced practice nurse, or physician assistant of a person who has
been diagnosed with diabetes, gestational diabetes, or pre-diabetes, in
accordance with standards adopted by the American Diabetes Association:</p>

<p class=MsoNormal style='line-height:150%'>     (a) Expenses for diabetes
self-management education or training to ensure that a person with diabetes,
gestational diabetes, or pre-diabetes can optimize metabolic control, prevent
and manage complications, and maximize quality of life.  Diabetes
self-management education shall be provided by an in-State provider who is:</p>

<p class=MsoNormal style='line-height:150%'>     (i) a licensed, registered, or
certified health care professional who is certified by the National
Certification Board of Diabetes Educators as a Certified Diabetes Educator, or
certified by the American Association of Diabetes Educators with a Board
Certified-Advanced Diabetes Management credential, including, but not limited
to: a physician, an advanced practice or registered nurse, a physician
assistant, a pharmacist, a chiropractor, a dietitian registered by a nationally
recognized professional association of dietitians, or a nutritionist holding a
certified nutritionist specialist (CNS) credential from the Board for
Certification of Nutrition Specialists; or</p>

<p class=MsoNormal style='line-height:150%'>     (ii) an entity meeting the
National Standards for Diabetes Self-Management Education and Support, as
evidenced by a recognition by the American Diabetes Association or
accreditation by the American Association of Diabetes Educators;</p>

<p class=MsoNormal style='line-height:150%'>     (b) Expenses for medical
nutrition therapy as an effective component of the person's overall treatment
plan upon a: diagnosis of diabetes, gestational diabetes, or pre-diabetes;
change in the beneficiary's medical condition, treatment, or diagnosis; or
determination of a physician, advanced practice nurse, or physician assistant
that reeducation or refresher education is necessary.  Medical nutrition
therapy shall be provided by an in-State provider who is a dietitian registered
by a nationally-recognized professional association of dietitians, or a
nutritionist holding a certified nutritionist specialist (CNS) credential from
the Board for Certification of Nutrition Specialists, who is familiar with the
components of diabetes medical nutrition therapy;</p>

<p class=MsoNormal style='line-height:150%'>     (c) For a person diagnosed
with pre-diabetes, items and services furnished under an in-State diabetes
prevention program that meets the standards of the National Diabetes Prevention
Program, as established by the federal Centers for Disease Control and
Prevention; and</p>

<p class=MsoNormal style='line-height:150%'>     (d) Expenses for any medically
appropriate and necessary supplies and equipment recommended or prescribed by a
physician, advanced practice nurse, or physician assistant for the management
and treatment of diabetes, gestational diabetes, or pre-diabetes, including,
but not limited to: equipment and supplies for self-management of blood
glucose; insulin pens; insulin pumps and related supplies; and other insulin
delivery devices;</p>

<p class=MsoNormal style='line-height:150%'>     (23) Expenses incurred for the
provision of group prenatal services to a pregnant woman, provided that:</p>

<p class=MsoNormal style='line-height:150%'>     (a) the provider of such
services, which shall include, but not be limited to, a federally qualified
health center or a community health center operating in the State:</p>

<p class=MsoNormal style='line-height:150%'>     (i) is a site accredited by
the Centering Healthcare Institute, or is a site engaged in an active
implementation contract with the Centering Healthcare institute, that utilizes
the Centering Pregnancy model; and</p>

<p class=MsoNormal style='line-height:150%'>     (ii) incorporates the
applicable information outlined in any best practices manual for prenatal and
postpartum maternal care developed by the Department of Health into the
curriculum for each group prenatal visit;</p>

<p class=MsoNormal style='line-height:150%'>     (b) each group prenatal care
visit is at least 1.5 hours in duration, with a. minimum of two women and a
maximum of 20 women in participation; and</p>

<p class=MsoNormal style='line-height:150%'>     (c) no more than 10 group
prenatal care visits occur per pregnancy.  As used in this paragraph,
&quot;group prenatal care services&quot; means a series of prenatal care visits
provided in a group setting which are based upon the Centering Pregnancy model
developed by the Centering Healthcare Institute and which include health
assessments, social and clinical support, and educational activities;</p>

<p class=MsoNormal style='line-height:150%'>     (24) Expenses incurred for the
provision of pasteurized donated human breast milk, which shall include human
milk fortifiers if indicated in a medical order provided by a licensed medical
practitioner, to an infant under the age of six months; provided that the milk
is obtained from a human milk bank that meets quality guidelines established by
the Department of Health and a licensed medical practitioner has issued a
medical order for the infant under at least one of the following circumstances:</p>

<p class=MsoNormal style='line-height:150%'>     (a) the infant is medically or
physically unable to receive maternal breast milk or participate in breast
feeding, or the infant's mother is medically or physically unable to produce
maternal breast milk in sufficient quantities or participate in breast feeding
despite optimal lactation support; or</p>

<p class=MsoNormal style='line-height:150%'>     (b) the infant meets any of
the following conditions:</p>

<p class=MsoNormal style='line-height:150%'>     (i) a body weight below
healthy levels, as determined by the licensed medical practitioner issuing the
medical order for the infant;</p>

<p class=MsoNormal style='line-height:150%'>     (ii) the infant has a
congenital or acquired condition that places the infant at a high risk for development
of necrotizing enterocolitis; or </p>

<p class=MsoNormal style='line-height:150%'>     (iii) the infant has a
congenital or acquired condition that may benefit from the use of donor breast
milk and human milk fortifiers, as determined by the Department of Health; </p>

<p class=MsoNormal style='line-height:150%'>     (25) Comprehensive tobacco
cessation benefits to an individual who is 18 years of age or older, or who is
pregnant.  Coverage shall include: brief and high intensity individual
counseling, brief and high intensity group counseling, and telemedicine as
defined by section 1 of P.L.2017, c.117 (C.45:1-61); all medications approved
for tobacco cessation by the U.S. Food and Drug Administration; and other
tobacco cessation counseling recommended by the Treating Tobacco Use and
Dependence Clinical Practice Guideline issued by the U.S. Public Health
Service.  Notwithstanding the provisions of any other law, rule, or regulation
to the contrary, and except as otherwise provided in this section:</p>

<p class=MsoNormal style='line-height:150%'>     (a) Information regarding the
availability of the tobacco cessation services described in this paragraph
shall be provided to all individuals authorized to receive the tobacco
cessation services pursuant to this paragraph at the following times: no later
than 90 days after the effective date of P.L.2019, c.473: upon the
establishment of an individual's eligibility for medical assistance; and upon
the redetermination of an individual's eligibility for medical assistance;</p>

<p class=MsoNormal style='line-height:150%'>     (b) The following conditions
shall not be imposed on any tobacco cessation services provided pursuant to
this paragraph: copayments or any other forms of cost-sharing, including
deductibles; counseling requirements for medication; stepped care therapy or
similar restrictions requiring the use of one service prior to another; limits
on the duration of services; or annual or lifetime limits on the amount,
frequency, or cost of services, including, but not limited to, annual or
lifetime limits on the number of covered attempts to quit; and</p>

<p class=MsoNormal style='line-height:150%'>     (c) Prior authorization
requirements shall not be imposed on any tobacco cessation services provided
pursuant to this paragraph except in the following circumstances where prior
authorization may be required: for a treatment that exceeds the duration
recommended by the most recently published United States Public Health Service
clinical practice guidelines on treating tobacco use and dependence; or for
services associated with more than two attempts to quit within a 12-month
period;</p>

<p class=MsoNormal style='line-height:150%'>     (26) Provided that there is
federal financial participation available, benefits for expenses incurred in
conducting a colorectal cancer screening in accordance with United States
Preventive Services Task Force recommendations.  The method and frequency of
screening to be utilized shall be in accordance with the most recent published
recommendations of the United States Preventive Services Task Force and as
determined medically necessary by the covered person's physician, in
consultation with the covered person.</p>

<p class=MsoNormal style='line-height:150%'>     No deductible, coinsurance,
copayment, or any other cost-sharing requirement shall be imposed for a
colonoscopy performed following a positive result on a non-colonoscopy,
colorectal cancer screening test recommended by the United States Preventive
Services Task Force; <b><span style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>and<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b></p>

<p class=MsoNormal style='line-height:150%'>     (27) (a) Within 24 months of
the effective date of P.L.2023, c.187 (C.30:4D-6u et al.), and conditional on
the receipt of all necessary federal approvals and the securing of federal
financial participation pursuant to section 2 of P.L.2023, c.187 (C.30:4D-6u),
community-based palliative care benefits which shall include, but not be
limited to, all of the following:</p>

<p class=MsoNormal style='line-height:150%'>     (i) specialized medical care
and emotional and spiritual support for beneficiaries with serious advanced
illnesses; </p>

<p class=MsoNormal style='line-height:150%'>     (ii) relief of symptoms, pain,
and stress of serious illness;</p>

<p class=MsoNormal style='line-height:150%'>     (iii) improvement of quality
of life for both the beneficiary and the beneficiary's family; and</p>

<p class=MsoNormal style='line-height:150%'>     (iv) appropriate care for any
age and for any stage of serious illness, along with curative treatment. </p>

<p class=MsoNormal style='line-height:150%'>     (b) Benefits provided under
this paragraph shall include, but shall not be limited to, services provided by
a hospice pursuant to paragraph (20) of subsection b. of this section, provided
that:</p>

<p class=MsoNormal style='line-height:150%'>     (i) hospice services may be
provided at the same time that curative treatment is available, to the extent
that services are not duplicative;</p>

<p class=MsoNormal style='line-height:150%'>     (ii) hospice services may be
provided to beneficiaries whose conditions may result in death, regardless of
the estimated length of the beneficiary's remaining period of life; and </p>

<p class=MsoNormal style='line-height:150%'>     (iii) the Division of Medical
Assistance and Health Services in the Department of Human Services may include
any other service deemed appropriate under the benefits provided under this
paragraph.</p>

<p class=MsoNormal style='line-height:150%'>     (c) Providers authorized to
deliver benefits provided under this paragraph shall include Medicaid-approved
licensed hospice agencies, Medicaid-approved home health agencies licensed to
provide hospice care, and other Medicaid-approved licensed health care
providers.</p>

<p class=MsoNormal style='line-height:150%'>     (d) Nothing in this paragraph
shall be construed to result in the elimination or reduction of covered
benefits or services under the Medicaid program.</p>

<p class=MsoNormal style='line-height:150%'>     (e) This paragraph shall not
affect a beneficiary's eligibility to receive, concurrently with services
provided for in this paragraph, any services, including home health services,
for which the beneficiary would have been eligible in the absence of this
paragraph, to the extent that services are not duplicative<u>; and</u></p>

<p class=MsoNormal style='line-height:150%'>     (<u>28)  Substance use
disorder services provided by a community-based organization to an individual
who has a substance use disorder and has been referred by a certified or
licensed health care provider to receive substance use disorder services from a
community-based organization.  </u></p>

<p class=MsoNormal style='line-height:150%'>     <u>As used in this paragraph,
community-based organization means a community-based organization licensed by
the Department of Health to provide substance use disorder services to Medicaid
recipients pursuant to section 2 of P.L.    , c.    (C.        ) (pending
before the Legislature as this bill).  A community-based organization may
include, but is not limited to, a harm reduction center</u>.</p>

<p class=MsoNormal style='line-height:150%'>     c.     Payments for the
foregoing services, goods and supplies furnished pursuant to this act shall be
made to the extent authorized by this act, the rules and regulations
promulgated pursuant thereto and, where applicable, subject to the agreement of
insurance provided for under this act.  The payments shall constitute payment
in full to the provider on behalf of the recipient.  Every provider making a
claim for payment pursuant to this act shall certify in writing on the claim
submitted that no additional amount will be charged to the recipient, the
recipient's family, the recipient's representative or others on the recipient's
behalf for the services, goods, and supplies furnished pursuant to this act.</p>

<p class=MsoNormal style='line-height:150%'>     No provider whose claim for
payment pursuant to this act has been denied because the services, goods, or
supplies were determined to be medically unnecessary shall seek reimbursement
form the recipient, his family, his representative or others on his behalf for
such services, goods, and supplies provided pursuant to this act; provided, however,
a provided may seek reimbursement from a recipient for services, goods, or
supplies not authorized by this act, if the recipient elected to receive the
services, goods or supplies with the knowledge that they were not authorized.</p>

<p class=MsoNormal style='line-height:150%'>     d.    Any individual eligible
for medical assistance (including drugs) may obtain such assistance from any
person qualified to <b><span style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>33<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> perform the
service or services required (including an organization which provides such
services, or arranges for their availability on a prepayment basis), who
undertakes to provide the individual such services.</p>

<p class=MsoNormal style='line-height:150%'>     No copayment or other form of
cost-sharing shall be imposed on any individual eligible for medical
assistance, except as mandated by federal law as a condition of federal
financial participation.</p>

<p class=MsoNormal style='line-height:150%'>     e.     Anything in this act to
the contrary notwithstanding, no payments for medical assistance shall be made
under this act with respect to care or services for any individual who:</p>

<p class=MsoNormal style='line-height:150%'>     (1) Is an inmate of a public
institution (except as a patient in a medical institution); provided, however,
that an individual who is otherwise eligible may continue to receive services
for the month in which he becomes an inmate, should the commissioner determine
to expand the scope of Medicaid eligibility to include such an individual,
subject to the limitations imposed by federal law and regulations, or</p>

<p class=MsoNormal style='line-height:150%'>     (2) Has not attained 65 years
of age and who is a patient in an institution for mental diseases, or</p>

<p class=MsoNormal style='line-height:150%'>     (3) Is over 21 years of age
and who is receiving inpatient psychiatric hospital services in a psychiatric
facility; provided, however, that an individual who was receiving such services
immediately prior to attaining age 21 may continue to receive such services
until the individual reaches age 22.  Nothing in this subsection shall prohibit
the commissioner from extending medical assistance to all eligible persons
receiving inpatient psychiatric services; provided that there is federal
financial participation available.</p>

<p class=MsoNormal style='line-height:150%'>     f.  (1) A third party as
defined in section 3 of P.L.1968, c.413 (C.30:4D-3) shall not consider a
person's eligibility for Medicaid in this or another state when determining the
person's eligibility for enrollment or the provision of benefits by that third
party.</p>

<p class=MsoNormal style='line-height:150%'>     (2) In addition, any provision
in a contract of insurance, health benefits plan, or other health care coverage
document, will, trust, agreement, court order, or other instrument which
reduces or excludes coverage or payment for health care-related goods and
services to or for an individual because of that individual's actual or
potential eligibility for or receipt of Medicaid benefits shall be null and
void, and no payments shall be made under this act as a result of any such
provision.</p>

<p class=MsoNormal style='line-height:150%'>     (3) Notwithstanding any
provision of law to the contrary, the provisions of paragraph (2) of this
subsection shall not apply to a trust agreement that is established pursuant to
42 U.S.C. s.1396p(d)(4)(A) or (C) to supplement and augment assistance provided
by government entities to a person who is disabled as defined in section
1614(a)(3) of the federal Social Security Act (42 31 U.S.C. s.1382c (a)(3)).</p>

<p class=MsoNormal style='line-height:150%'>     g.    The following services
shall be provided to eligible medically needy individuals as follows:</p>

<p class=MsoNormal style='line-height:150%'>     (1) Pregnant women shall be
provided prenatal care and delivery services and postpartum care, including the
services cited in subsections a.(1), (3), and (5) of this section and
subsections b.(1)-(10), (12), (15), and (17) of this section, and nursing
facility services cited in subsection b.(13) of this section.</p>

<p class=MsoNormal style='line-height:150%'>     (2) Dependent children shall
be provided with services cited in subsections a.(3) and (5) of this section
and subsections b.(1), (2), (3), (4), (5), (6), (7), (10), (12), (15), and (17)
of this section, and nursing facility services cited in subsection b.(13) of
this section.</p>

<p class=MsoNormal style='line-height:150%'>     (3) Individuals who are 65
years of age or older shall be provided with services cited in subsections
a.(3) and (5) of this section and subsections b.(1)-(5), (6) excluding
prescribed drugs, (7), (8), (10), (12), (15), and (17) of this section, and
nursing facility services cited in subsection b.(13) of this section.</p>

<p class=MsoNormal style='line-height:150%'>     (4) Individuals who are blind
or disabled shall be provided with services cited in subsections a.(3) and (5)
of this section and subsections b.(1)-(5), (6) excluding prescribed drugs, (7),
(8), (10), 3 (12), (15), and (17) of this section, and nursing facility
services cited in subsection b.(13) of this section.</p>

<p class=MsoNormal style='line-height:150%'>     (5) (a) Inpatient hospital
services, subsection a.(1) of this section, shall only be provided to eligible
medically needy individuals, other than pregnant women, if the federal
Department of Health and Human Services discontinues the State's waiver to
establish inpatient hospital reimbursement rates for the Medicare and Medicaid
programs under the authority of section 601(c)(3) of the Social Security Act
Amendments of 1983, Pub.L.98-21 (42 U.S.C. s.1395ww(c)(5)).  Inpatient hospital
services may be extended to other eligible medically needy individuals if the
federal Department of Health and Human Services directs that these services be
included.</p>

<p class=MsoNormal style='line-height:150%'>     (b) Outpatient hospital
services, subsection a.(2) of this section, shall only be provided to eligible
medically needy individuals if the federal Department of Health and Human
Services discontinues the State's waiver to establish outpatient hospital
reimbursement rates for the Medicare and Medicaid programs under the authority
of section 601(c)(3) of the Social Security Amendments of 1983, Pub.L.98-21 (42
U.S.C. s.1395ww(c)(5)).  Outpatient hospital services may be extended to all or
to certain medically needy individuals if the federal Department of Health and
Human Services directs that these services be included.  However, the use of
outpatient hospital services shall be limited to clinic services and to
emergency room services for injuries and significant acute medical conditions.</p>

<p class=MsoNormal style='line-height:150%'>     (c) The division shall monitor
the use of inpatient and outpatient hospital services by medically needy
persons.</p>

<p class=MsoNormal style='line-height:150%'>     h.    In the case of a
qualified disabled and working individual pursuant to section h6408 of Pub.L.101-239
(42 U.S.C. s.1396d), the only medical assistance provided under this act shall
be the payment of premiums for Medicare part A under 42 U.S.C. ss.1395i-2 and
1395r.</p>

<p class=MsoNormal style='line-height:150%'>     i.     In the case of a
specified low-income Medicare beneficiary pursuant to 42 U.S.C.
s.1396a(a)10(E)iii, the only medical assistance provided under this act shall
be the payment of premiums for Medicare part B under 42 U.S.C. s.1395r as
provided for in 42 U.S.C. s.1396d(p)(3)(A)(ii).</p>

<p class=MsoNormal style='line-height:150%'>     j.     In the case of a
qualified individual pursuant to 42 U.S.C. s.1396a(aa), the only medical
assistance provided under this act shall be payment for authorized services
provided during the period in which the individual requires treatment for
breast or cervical cancer, in accordance with criteria established by the
commissioner.</p>

<p class=MsoNormal style='line-height:150%'>     k.    In the case of a
qualified individual pursuant to 42 U.S.C. s.1396a(ii), the only medical
assistance provided under this act shall be payment for family planning
services and supplies as described at 42 U.S.C. s.1396d(a)(4)(C), including
medical diagnosis and treatment services that are provided pursuant to a family
planning service in a family planning setting.</p>

<p class=MsoNormal style='line-height:150%'>(cf: P.L.2023, c.187, s.1)</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     8.  (New section) The
Commissioner of Human Services shall apply for such State plan amendments or
waivers as may be necessary to implement the provisions of this act and to
secure federal financial participation for State Medicaid expenditures under
the federal Medicaid program.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     9.  The Commissioners of
Health and Human Services shall adopt rules and regulations, pursuant to the
Administrative Procedure Act, P.L.1968, c.410 (C.52:14B-1 et seq.), as are
necessary to implement the provisions of this act.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     10.  This act shall take
effect immediately.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'>STATEMENT</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     This bill expands access to
substance use disorder treatment in the State by revising various laws and
regulations concerning substance use disorder and opioid treatment programs and
establishing Medicaid coverage for substance use disorder services provided by
community-based organizations.</p>

<p class=MsoNormal style='line-height:150%'>     The bill clarifies current law
to remove language concerning an outdated certificate of need requirement for a
substance use disorder treatment center located within 500 feet from any
building in this State used for the instruction of children between the ages of
five and 18 years.</p>

<p class=MsoNormal style='line-height:150%'>     The bill provides that an opioid
treatment program may voluntarily establish a medication unit that will be
associated with a single primary opioid treatment program that will oversee the
units operations.  All required services that cannot be performed at the
medication unit will be performed by the primary opioid treatment program.</p>

<p class=MsoNormal style='line-height:150%'>     A medication unit may provide
the following services if it provides appropriate privacy and adequate space: 
intake and initial psychosocial and appropriate medical assessments; initiation
of medication-assisted treatment including, but not limited to, methadone,
buprenorphine, or naltrexone; and telecounseling services.</p>

<p class=MsoNormal style='line-height:150%'>     The bill provides that an
opioid treatment program:</p>

<p class=MsoListParagraphCxSpFirst style='text-indent:-.25in;line-height:150%'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>will not be required to engage, employ, or contract with a
pharmacist;</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in;line-height:150%'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>may only require a patient to receive a minimum of eight random
drug screenings per year;</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in;line-height:150%'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>will provide or coordinate harm reduction services for each
patient as appropriate to the patients treatment plan; and</p>

<p class=MsoListParagraphCxSpLast style='text-indent:-.25in;line-height:150%'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>will establish a counseling schedule for each patient based on an
individualized treatment plan approved and documented by the patients multidisciplinary
treatment team.</p>

<p class=MsoNormal style='line-height:150%'>     The bill provides that a
patient will not be precluded from receiving treatment or medication for opioid
use disorder from an opioid treatment program solely on the basis of the patients
refusal of counseling.  The bill provides that an opioid treatment programs
discharge policy may not permit the administrative discharge of a patient due
to missed doses, non-participation, and continued illicit substance use, except
under certain circumstances as outlined in the bill. </p>

<p class=MsoNormal style='line-height:150%'>     The bill permits a patient to
receive treatment from another opioid treatment program under certain
conditions provided under the bill.</p>

<p class=MsoNormal style='line-height:150%'>     The bill establishes certain
Medicaid coverage for substance use disorder services provided by a licensed community-based
organization.</p>

<p class=MsoNormal style='line-height:150%'>     The bill requires the Commissioner
of Health, in consultation with the Commissioner of Human Services, to establish
standards and requirements for the licensure of community-based organizations
and for the provision of substance use disorder services by licensed
community-based organizations.  Under the bill, the commissioner will establish
a program to provide training and technical assistance to help community-based
organizations meet any licensure and provider enrollment standards established
by the commissioner and the Medicaid program. </p>

</div>

</body>

</html>
